Literature DB >> 1922028

Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function.

A Zentella1, F M Weis, D A Ralph, M Laiho, J Massagué.   

Abstract

The growth-suppressive function of the retinoblastoma susceptibility gene product, RB, has been implicated in the mediation of growth inhibition and negative regulation of certain proliferation related genes by transforming growth factor-beta 1 (TGF-beta 1). Early gene responses to TGF-beta 1 were examined in order to determine their dependence on the cell cycle and on the growth-suppressive function of RB. TGF-beta 1, which rapidly elevates the steady-state level of junB and PAI-1 mRNAs and decreases that of c-myc mRNA, induces these responses in S-phase populations of Mv1Lu lung epithelial cells containing RB in a phosphorylated state. Since in this state RB is presumed to lack growth-suppressive activity, the response to TGF-beta 1 was also examined in DU145 human prostate carcinoma cells whose mutant RB product lacks growth-suppressive function. In these cells, TGF-beta 1 also decreases c-myc expression at the transcription initiation level. These results suggests that the c-myc, junB, and PAI-1 responses to TGF-beta 1 are not restricted to the G1 phase of the cell cycle and that down-regulation of c-myc expression by TGF-beta 1 can occur through a mechanism independent from the growth-suppressive function of RB.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922028      PMCID: PMC361474          DOI: 10.1128/mcb.11.10.4952-4958.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.

Authors:  F T Boyd; J Massagué
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

2.  Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta.

Authors:  R J Coffey; C C Bascom; N J Sipes; R Graves-Deal; B E Weissman; H L Moses
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

3.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.

Authors:  D L Bentley; M Groudine
Journal:  Nature       Date:  1986 Jun 12-18       Impact factor: 49.962

4.  Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

Authors:  P A Andreasen; A Riccio; K G Welinder; R Douglas; R Sartorio; L S Nielsen; C Oppenheimer; F Blasi; K Danø
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

5.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

6.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

7.  Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.

Authors:  L Pertovaara; L Sistonen; T J Bos; P K Vogt; J Keski-Oja; K Alitalo
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

8.  TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression.

Authors:  K Takehara; E C LeRoy; G R Grotendorst
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

9.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

Authors:  H J Huang; J K Yee; J Y Shew; P L Chen; R Bookstein; T Friedmann; E Y Lee; W H Lee
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

10.  Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.

Authors:  J L Andres; K Stanley; S Cheifetz; J Massagué
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  20 in total

1.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.

Authors:  Trevor A Petrel; Robert W Brueggemeier
Journal:  J Cell Biochem       Date:  2003-01-01       Impact factor: 4.429

3.  Evidence for the involvement of protein kinase activity in transforming growth factor-beta signal transduction.

Authors:  M Ohtsuki; J Massagué
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

4.  Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.

Authors:  B J Warner; S W Blain; J Seoane; J Massagué
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  Transforming growth factor beta induces myoblast differentiation in the presence of mitogens.

Authors:  A Zentella; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

6.  Improved specificity of RT-PCR amplifications using nested cDNA primers.

Authors:  G Baier; D Telford; E Gulbins; N Yamada; T Kawakami; A Altman
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

7.  Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures.

Authors:  R J McAnulty; N A Hernández-Rodriguez; S E Mutsaers; R K Coker; G J Laurent
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

8.  Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.

Authors:  Brian K Law; Anna Chytil; Nancy Dumont; Elizabeth G Hamilton; Mary E Waltner-Law; Mary E Aakre; Cassondra Covington; Harold L Moses
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

9.  RNA fingerprinting using arbitrarily primed PCR identifies differentially regulated RNAs in mink lung (Mv1Lu) cells growth arrested by transforming growth factor beta 1.

Authors:  D Ralph; M McClelland; J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

Review 10.  The cell cycle and the retinoblastoma protein family.

Authors:  M E Ewen
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.